BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37284891)

  • 21. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
    Cao X; Dang L; Zheng X; Lu Y; Lu Y; Ji R; Zhang T; Ruan X; Zhi J; Hou X; Yi X; Li MJ; Gu T; Gao M; Zhang L; Chen Y
    Thyroid; 2019 Jun; 29(6):809-823. PubMed ID: 30924726
    [No Abstract]   [Full Text] [Related]  

  • 22. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways.
    Li L; Wang X; Sharvan R; Gao J; Qu S
    Biomed Pharmacother; 2017 Nov; 95():1225-1231. PubMed ID: 28931215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
    Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diallyl trisulphide, a H
    Zhang L; Xu S; Cheng X; Zheng J; Wang Y; Wu J; Wang X; Wu L; Yu H; Bao J
    Phytother Res; 2021 Jun; 35(6):3428-3443. PubMed ID: 33751676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
    Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
    Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells.
    Jensen K; Bikas A; Patel A; Kushchayeva Y; Costello J; McDaniel D; Burman K; Vasko V
    Endocr Relat Cancer; 2017 Mar; 24(3):147-156. PubMed ID: 28137980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest.
    Liu RY; Li JP
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2435-43. PubMed ID: 25268087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
    Wang W; Zhou J; Zhao L; Chen S
    Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
    Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
    Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
    Pourbagheri-Sigaroodi A; Bashash D; Safaroghli-Azar A; Farshi-Paraasghari M; Momeny M; Mansoor FN; Ghaffari SH
    Eur J Pharmacol; 2019 Mar; 846():49-62. PubMed ID: 30658112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.
    Fallahi P; Ferrari SM; La Motta C; Materazzi G; Bocci G; Da Settimo F; Miccoli P; Antonelli A
    Endocrine; 2016 Jul; 53(1):136-44. PubMed ID: 26286966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer.
    Enomoto K; Zhu X; Park S; Zhao L; Zhu YJ; Willingham MC; Qi J; Copland JA; Meltzer P; Cheng SY
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2268-2280. PubMed ID: 28368473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells.
    Allegri L; Baldan F; Mio C; Puppin C; Russo D; Kryštof V; Damante G
    Oncol Rep; 2016 Apr; 35(4):2413-8. PubMed ID: 26884249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Apigenin on glycometabolism and cell death in an anaplastic thyroid cancer cell line.
    Heydarzadeh S; Moshtaghie AA; Daneshpour M; Hedayati M
    Toxicol Appl Pharmacol; 2023 Sep; 475():116626. PubMed ID: 37437745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.
    Pinto N; Prokopec SD; Vizeacoumar F; Searle K; Lowerison M; Ruicci KM; Yoo J; Fung K; MacNeil D; Lacefield JC; Leong HS; Mymryk JS; Barrett JW; Datti A; Boutros PC; Nichols AC
    PLoS One; 2018; 13(11):e0207152. PubMed ID: 30419054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
    Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
    Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
    Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
    Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.